Navigation Links
Flextronics Announces Expansion of Medical Disposables Offering
Date:10/21/2009

SINGAPORE, Oct. 21 /PRNewswire-FirstCall/ -- Flextronics (Nasdaq: FLEX) is expanding its medical disposables offering and has signed an agreement to acquire Slomedical S.R.O through a share purchase agreement. Slomedical is a leading European manufacturer of disposable medical devices ranging from tubing sets to complex devices for minimally-invasive surgery. This deal is expected to close before the end of the calendar year, pending required regulatory clearances.

Upon completion, this strategic acquisition will expand Flextronics's overall capability for medical disposables through Slomedical's low cost European location in Slovakia and allow Flextronics to significantly advance its disposables strategy throughout Europe.

"We evaluated many companies to determine the best fit for the acquisition of our organization. Flextronics is the ideal organization based on its ability to augment our current capabilities and its significant market strength in the medical space," said Frank Sodha, managing director, Slomedical. "We have grown to a point that in order to expand and support the growing needs of our customers, we must partner with a larger organization such as Flextronics. We are all very excited and look forward to working with the team."

In addition to today's announced planned acquisition of Slomedical, Flextronics recently completed a major expansion of its Tijuana, Mexico campus which is dedicated to disposable medical device manufacturing. Flextronics's Tijuana campus now includes key vertical integration capabilities of plastic injection molding and plastic extrusion as well as world class clean room assembly operations. With the addition of these capabilities at its Tijuana Medical campus, Flextronics is able to drive value for its customers through lower costs and faster time-to-market.

"The major expansion of our Tijuana, Mexico campus and the imminent acquisition of Slomedical will significantly expand our ability to serve the global disposables medical device market for European and multi-national customers," said Dan Croteau, president, Flextronics Medical. "Upon completion of the deal, we look forward to expanding Slomedical's well established low-cost operations and investing in additional manufacturing capabilities, quality systems and design services to deliver more value, lower costs and faster time-to-market to our customers. On behalf of the Flextronics team, we look forward to working with the Slomedical team to continue to grow our businesses together."

About Flextronics

Headquartered in Singapore (Singapore Reg. No. 199002645H), Flextronics is a leading Electronics Manufacturing Services (EMS) provider focused on delivering complete design, engineering and manufacturing services to automotive, computing, consumer, industrial, infrastructure, medical and mobile OEMs. Flextronics helps customers design, build, ship, and service electronics products through a network of facilities in 30 countries on four continents. This global presence provides design and engineering solutions that are combined with core electronics manufacturing and logistics services, and vertically integrated with components technologies, to optimize customer operations by lowering costs and reducing time to market. For more information, please visit www.flextronics.com.

SOURCE Flextronics


'/>"/>
SOURCE Flextronics
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... ZappRx, Inc ., a digital health company focused on modernizing ... closed $25 million in Series B funding led by Qiming ... Seattle that is part of a broader ... round included participation from SR One , who led ... (formerly Google Ventures). As part of the financing, Mark ...
(Date:4/20/2017)... , April 20, 2017 ... platform, the first non-viral gene expression technology that enables ... the eye to address a wide range of ophthalmic ... Medicines and Healthcare products Regulatory Agency (MHRA) to advance ... ...
(Date:4/19/2017)... April 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) ... & Co. Healthcare Investor Conference 2017 at the Sheraton Hotel in ... , Chief Executive Officer of the Company is scheduled to present ... Richard Bear and the Chairman of the Board, Tony ... ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... 25, 2017 , ... The doctors at Wall Centre Dental are now expanding ... and require sedation to receive dental care. The doctors offer three treatment options to ... cleanings to oral surgery, at their dental office in Vancouver. Wall Centre Dental is ...
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies are held ... with process innovation in drug formulation and manufacturing. CoreRx offers its clients ... equipment in support of their development and manufacturing goals. , The company ...
(Date:4/25/2017)... ... 25, 2017 , ... Buyers and sellers in the thriving multi-billion dollar cannabis ... –can’t help but be heartened by the industry’s current surge. But another thing that ... “skunk smell.” At last they can simply, safely and effectively end their aroma ...
(Date:4/25/2017)... ... April 25, 2017 , ... Emergency Physician and Distinguished Professor of Emergency Medicine ... Outliers in Writing, set to publish in summer 2017. , Dr. Bobrow, MD, ... of Arizona College of Medicine. He also serves as Medical Director for the Bureau ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... instrument solutions, announces the continuation of its strategic partnership with and platinum sponsorship ... developing nations in the safe and effective management of complex spine deformity cases, ...
Breaking Medicine News(10 mins):